Medical Xpress2 年
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial
More information: Sham Mailankody et al, Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results, Nature Medicine (2023). DOI ...